Teleflex TFX EBITDA

EBITDA at other companies

Becton, Dickinson and CompanyBDX

$656M-30.9%

HaemoneticsHAE

$84.57M+2.3%

Utah Medical ProductsUTMD

$3.24M-16.2%

Merit Medical SystemsMMSI

$74.65M+6.2%

ICU MedicalICUI

$88.74M+47.3%

Boston ScientificBSX

$1.45B+16.5%

FAQ

What is Teleflex's EBITDA?

Teleflex (TFX) reported EBITDA of $122.64M in Q2 2026.

How has Teleflex's EBITDA changed year-over-year?

Teleflex's EBITDA decreased by 4.2% year-over-year, from $128.03M to $122.64M.

What is the long-term trend for Teleflex's EBITDA?

Over 3 years (2021 to 2025), Teleflex's EBITDA has grown at a -27.5% compound annual growth rate (CAGR), from $865.46M to $329.34M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.